LinkedIn Share

CPHI Milan served as a bridge to a partnership with Mabion


  • CPHI Milan took place from October 6 to 8, 2026, at Fiera Milano in Italy, convening over 63,000 professionals from more than 160 countries. It is the world’s largest pharma trade fair.
  • For Mabion, CPHI Milan was a wonderful opportunity to reconnect with our clients and forge new business relationships. As part of our networking efforts, we held a total of over 200 meetings throughout the event.

Mabion at the Largest Pharma Trade Show in Europe

This year’s trade show transformed alongside the industry. As a result, its program was expanded to include new topics relevant to today’s pharma. These included new zones dedicated to AI & Tech, Cold Chain & Pharma Logistics, and Contamination Control. The agenda also expanded to include additional events. CPHI 2026 hosted the Sustainability Summit and Leadership Summit, which addressed the new wave of topics in the pharmaceutical industry. Over 250 experts shared their expertise throughout the event.

Mabion team at the booth during CPHI Milan 2026
The entire Mabion team at our booth during CPHI Milan 2026.

During the three days of the CPHI Milan trade fair, the Mabion team held numerous fruitful meetings with existing partners and potential customers. The discussions highlighted Mabion’s comprehensive capabilities in biologic drug development and manufacturing. In recent months, our co-development offerings have also expanded, opening up new opportunities for strategic collaboration.

CPHI Milan 2026 was an exceptional success for Mabion. The impressive number of depth discussions reflected the value of building long-term relationships within the biopharmaceutical sector. We strengthened relationships with existing partners while opening new discussions with companies from across the global biopharmaceutical industry. The quality of these interactions gives us confidence in our commercial direction and the opportunities ahead. I am particularly proud of our team’s outstanding commitment, professionalism, and energy throughout the event. 

Detlef Behrens, Chief Business Affairs Officer of Mabion

Key Discussions with Partners at CPHI Milan

The true value of CPHI lies in the conversations that will continue long after the exhibition has ended. With an intensive schedule of meetings, we had an excellent opportunity to strengthen Mabion’s presence in the international biopharma market and demonstrate the breadth of our offering.

CPHI was once again a brilliant opportunity for face-to-face meetings, which remain the foundation of every strong relationship. Our discussions reinforced the growing importance of flexible partnership models that go beyond traditional CDMO services – a key element of our value proposition. We placed particular emphasis on co-development, exploring how combining expertise and aligning strategic goals can help our partners advance their projects. Our focus now is to build on this momentum and turn these conversations into lasting, mutually beneficial collaborations. We return from Milan with heightened market visibility, promising opportunities, and a clear vision for transforming these meaningful connections into long-term business partnerships.

Judyta Suskiewicz, Director of Business Development at Mabion

We look forward to continuing the contacts we established in Milan. We are committed to developing partnerships based on trust, complementary expertise, and long-term value creation.

See you next year at CPHI Frankfurt!

Prepared by:

Jakub Knurek
Jakub Knurek

Marketing Specialist

j.knurek@mabion.eu